Atlas Trials

PEG-interferon Alfa-2a add-on Study in HBeAg Negative Chronic Hepatitis B Patients

Clinical trial NCT01373684 · COMPLETED

Trial details

NCT number
NCT01373684
Sponsor
Foundation for Liver Research
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Hepatitis B
Start date
2012-05-25
Primary completion
2019-10-28
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.